COR Therapeutics Beats Estimates By a Penny

Earnings Scorecard
Actual Estimated* Year-Ago
$0.02 $0.01 -$0.11

COR Therapeutics ( CORR) posted fourth-quarter earnings Tuesday that were slightly above Wall Street estimates.

The pharmaceutical products company said it earned 2 cents a share for the quarter, significantly better than the 11-cent-a-share loss posted in the year-ago period. Six analysts polled by First Call/Thomson Financial were expecting the company to earn a penny in the quarter.

Shares of COR lost $1.19, or 2.8%, to $40.88 in recent Nasdaq trading.

More from Investing

12 Stocks That Make Up the GLUM Index

12 Stocks That Make Up the GLUM Index

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Worth a Stunning $6.6 Trillion, Tech Stocks Have Taken Over the Market

Worth a Stunning $6.6 Trillion, Tech Stocks Have Taken Over the Market

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Here's Why Snap Shares Climbed Monday

Here's Why Snap Shares Climbed Monday